share_log

UBS Oconnor LLC Has $4.88 Million Holdings in CONX Corp. (NASDAQ:CONX)

UBS Oconnor LLC Has $4.88 Million Holdings in CONX Corp. (NASDAQ:CONX)

瑞銀奧康納有限責任公司在康克斯公司擁有 488 萬美元的控股權(納斯達克:康克斯)
Financial News Live ·  2023/02/19 02:01

UBS Oconnor LLC lessened its position in shares of CONX Corp. (NASDAQ:CONX – Get Rating) by 9.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 487,994 shares of the company's stock after selling 49,050 shares during the quarter. UBS Oconnor LLC owned approximately 0.52% of CONX worth $4,880,000 as of its most recent filing with the Securities and Exchange Commission.

根據最近向證券交易委員會提交的文件,瑞銀 Oconnor 有限責任公司(NASDAQ:CONX-獲得評級)在第三季度將其在 CONX 公司(NASDAQ:CONX-獲得評級)的地位下降了 9.1%。機構投資者在本季度賣出 49,050 股股票後,擁有該公司股票的 487,994 股股票。從最近向證券交易委員會提交的文件中,瑞銀歐康納有限責任公司擁有約 0.52% 的 CONX,價值 4,880,000 美元。

Several other institutional investors also recently modified their holdings of the company. UBS Group AG boosted its stake in CONX by 80.6% in the 1st quarter. UBS Group AG now owns 6,522 shares of the company's stock valued at $64,000 after buying an additional 2,910 shares in the last quarter. Landscape Capital Management L.L.C. bought a new stake in shares of CONX during the second quarter worth $133,000. Berkley W R Corp bought a new stake in shares of CONX during the first quarter worth $174,000. CSS LLC IL acquired a new position in CONX in the second quarter valued at about $297,000. Finally, ARS Investment Partners LLC grew its position in shares of CONX by 90.0% during the 3rd quarter. ARS Investment Partners LLC now owns 38,000 shares of the company's stock worth $380,000 after buying an additional 18,000 shares during the period. Institutional investors and hedge funds own 77.88% of the company's stock.

其他一些機構投資者最近還修改了他們對該公司的持有權。瑞銀集團股份公司在第一季度將其在 CONX 的股份提高了 80.6%。瑞銀集團股份有限公司在上一季度額外購買 2,910 股股份後,擁有該公司股票價值 64,000 美元的 6,522 股。景觀資本管理有限責任公司在第二季度買入了 CONX 股份的新股份,價值 133,000 美元。伯克利 W R 公司在第一季度價值 174,000 美元期間購買了康克斯股份的新股份。有限責任公司 IL 在第二季度收購了 CONX 的新職位,價值約為 297,000 美元。最後,ARS 投資合作夥伴有限責任公司在 CONX 的股份中第三季度增長了 90.0%。在此期間,ARS 投資合作夥伴有限責任公司現在擁有該公司股票 38,000 股價值 380,000 美元的股票。機構投資者和對沖基金擁有公司股票的 77.88%。

Get
取得
CONX
連續
alerts:
警報:

CONX Stock Performance

康克斯股票表現

Shares of NASDAQ:CONX opened at $10.10 on Friday. The firm's 50 day simple moving average is $10.02 and its 200 day simple moving average is $10.01. CONX Corp. has a fifty-two week low of $9.80 and a fifty-two week high of $10.20.

納斯達克:康克斯的股票上週五以 10.10 美元開盤。該公司的 50 天簡單移動平均線為 10.02 美元,其 200 天簡單移動平均線為 10.01 美元。康克斯公司擁有五十兩周低點 9.80 美元,五十二周新高為 10.20 美元。

CONX Profile

CONX 配置文件

(Get Rating)

(取得評分)

CONX Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses or assets. It intends to focus its search on identifying a prospective target operating in the technology, media, and telecommunications industries, including wireless communications industry.

康克斯公司沒有重大業務。該公司專注於與一個或多個企業或資產進行合併,資本證券交易所,資產收購,股票購買,重組或類似業務合併。該公司打算將焦點集中在科技、媒體和電信行業(包括無線通訊產業)中營運的潛在目標。

See Also

另請參閱

  • Get a free copy of the StockNews.com research report on CONX (CONX)
  • MarketBeat Week in Review – 2/13 – 2/17
  • Deere Stock Raises Outlook and is Ready to Power Higher
  • DraftKings Crowning Achievement: Leverage
  • Tesla Stock Comeback Is Picking Up Steam
  • How Abbott Labs, AbbVie Could Profit on Seizure Drug Formula
  • 獲取有關康克斯(康克斯)的研究報告的免費副本
  • 市場節拍週的回顧 — 2 月 13 日 — 2/17
  • 迪爾股票提高了前景,並準備提高動力
  • 起草加冕成就:槓桿
  • 特斯拉股票復出正在拿起蒸汽
  • 雅培實驗室,艾伯維如何通過扣押藥物配方獲利

Receive News & Ratings for CONX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CONX and related companies with MarketBeat.com's FREE daily email newsletter.

接收康克斯日報的新聞和評分 -在下面輸入您的電子郵件地址,以通過 MarketBeat.com 的免費每日電子郵件時事通訊接收 CONX 和相關公司的最新新聞和分析師評級的簡要每日摘要。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論